Author

Chikako Yanagiba

Observed name: C. Yanagiba

Institution: Karius, Inc. (United States)

Observed institutions: University of Minnesota, Karius, Inc. (United States)

ORCID: 0000-0001-8987-991X

Observed ORCID: 0000-0001-8987-991X

OpenAlex ID: A5011281280

Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination

2020 · Mizuho Sato-Dahlman, Christopher J. LaRocca, et al. · Cancers · 54

Final Results from Phase 1 Study of Briquilimab, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning, Shows Durable Remissions in Older Adults with Acute Myeloid Leukemia in Complete Remission and Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation

2023 · Arpita Gandhi, Andrew Artz, et al. · Blood · 11

Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells

2020 · Hideki Yoshida, Mizuho Sato-Dahlman, et al. · Translational Oncology · 9

Nonmyeloablative conditioning combined with the anti-CD117 antibody briquilimab in older adults with high-risk AML and MDS

2026 · Lori Muffly, Catherine J. Lee, et al. · Blood · 8

Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated, Facilitates Chimerism and Clearance of Minimal Residual Disease in Older Adults with MDS/AML Undergoing Allogeneic HCT

2022 · Lori Muffly, Catherine J. Lee, et al. · Transplantation and Cellular Therapy · 3

Briquilimab Potently Inhibits Stem Cell Factor (scf)/c-kit Signaling, and Mast Cell (mc) Degranulation and Survival

2024 · H. Bouzid, C. Kwan, et al. · Annals of Allergy Asthma & Immunology

Immune Biomarkers Associated with Chronic Gvhd in Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning in Older Adults with MDS/AML Undergoing Allogeneic HCT

2023 · Minyoung Youn, Lori Muffly, et al. · Transplantation and Cellular Therapy

Subanalysis from Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning, Shows Durable Remissions in Older Adults with Acute Myleoid Leukemia in Complete Remission Undergoing Allogeneic Hematopoietic Cell Transplantation

2023 · Lori Muffly, Catherine J. Lee, et al. · Transplantation and Cellular Therapy

Sa285 EFFICIENT SYSTEMIC TREATMENT WITH MESOTHELIN-TARGETED ONCOLYTIC ADENOVIRUS IN PANCREATIC CANCER

2021 · Mizuho Sato-Dahlman, Kari Jacobsen, et al. · Gastroenterology

Abstract 5921: Systemic treatment with mesothelin-targeted oncolytic adenovirus shows efficacy patient-derived xenograft of pancreatic cancer

2018 · Mizuho Sato-Dahlman, Yoshiaki Miura, et al. · Cancer Research

Su1312 - Systemic Treatment with Mesothelin-Targeted Oncolytic Adenovirus Shows Efficacy Patient-Derived Xenograft of Pancreatic Cancer

2018 · Mizuho Sato-Dahlman, Yoshiaki Miura, et al. · Gastroenterology

Works count: 11

Citation count: 85

H-index: 4

I10-index: 2